The DOI matches its Crossref record; 297 of the 297 references it cites were found in a registry or an index.
Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function
Open accessAbstract
Huntington’s disease (HD) is a progressive, fatal neurological condition caused by an expansion of CAG (glutamine) repeats in the coding region of the Huntington gene. To date, there is no cure but great strides have been made to understand pathophysiological mechanisms. In particular, genetic animal models of HD have been instrumental in elucidating the progression of behavioral and physiological alterations, which had not been possible using classic neurotoxin models. Our groups have pioneered the use of transgenic HD mice to examine the excitotoxicity hypothesis of striatal neuronal dysfunction and degeneration, as well as alterations in excitation and inhibition in striatum and cerebral cortex. In this review, we focus on synaptic and receptor alterations of striatal medium-sized spiny (MSNs) and cortical pyramidal neurons in genetic HD mouse models. We demonstrate a complex series of alterations that are region-specific and time-dependent. In particular, many changes are bidirectional depending on the degree of disease progression, i.e., early versus late, and also on the region examined. Early synaptic dysfunction is manifested by dysregulated glutamate release in striatum followed by progressive disconnection between cortex and striatum. The differential effects of altered glutamate release on MSNs originating the direct and indirect pathways is also elucidated, with the unexpected finding that cells of the direct striatal pathway are involved early in the course of the disease. In addition, we review evidence for early N-methyl-D-aspartate receptor (NMDAR) dysfunction leading to enhanced sensitivity of extrasynaptic receptors and a critical role of GluN2B subunits. Some of the alterations in late HD could be compensatory mechanisms designed to cope with early synaptic and receptor dysfunctions. The main findings indicate that HD treatments need to be designed according to the stage of disease progression and should consider regional differences.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A synaptic model of memory: long-term potentiation in the hippocampus
Bliss, T. V. P., & Collingridge, G. L. (1993) · Nature · doi:10.1038/361031a0 · Cited by 11,566 · cited 1×
“Therefore, NMDARs serve as coincidence detectors for inducing activity-dependent synaptic plasticity (Bliss and Collingridge, 1993).”
BackgroundMACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
The functional anatomy of basal ganglia disorders
Albin, R. L., Young, A. B., & Penney, J. B. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90074-x · Cited by 5,353
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
Coyle, J. T., & Puttfarcken, P. (1993) · Science · doi:10.1126/science.7901908 · Cited by 3,762
Glutamate receptor ion channels
Mayer, M. L. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.05.004 · Cited by 3,640
The Glutamate Receptor Ion Channels
Dingledine, R., Borges, K., Bowie, D., & Traynelis, S. F. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01394-2 · Cited by 3,554 · cited 1×
“These subunits determine differences in receptor channel properties, pharmacology, and temporal and spatial brain distribution (Dingledine et al., 1999; Cull-Candy and Leszkiewicz, 2004).”
BackgroundMangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R. (1990) · Science · doi:10.1126/science.2147780 · Cited by 2,967
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
Epstein, F. H., Lipton, S. A., & Rosenberg, P. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300907 · Cited by 2,658
Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain
DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., Vonsattel, J. P., & Aronin, N. (1997) · Science · doi:10.1126/science.277.5334.1990 · Cited by 2,439
Neuropathological Classification of Huntingtonʼs Disease
VONSATTEL, J.-P., MYERS, R. H., STEVENS, T. J., FERRANTE, R. J., BIRD, E. D., & RICHARDSON, E. P. (1985) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198511000-00003 · Cited by 2,227
Davies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., Ross, C. A., Scherzinger, E., Wanker, E. E., Mangiarini, L., & Bates, G. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80513-9 · Cited by 2,181
Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways
Hardingham, G. E., Fukunaga, Y., & Bading, H. (2002) · Nature Neuroscience · doi:10.1038/nn835 · Cited by 1,686
Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
Hardingham, G. E., & Bading, H. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2911 · Cited by 1,644 · cited 3×
“…and activation of cell death signaling p38 and c-Jun N-terminal Kinase MitogenActivated Protein Kinases (JNK MAPKs) (Hardingham et al., 2002; Cao et al., 2004; Ivanov et al., 2006; Leveille et al., 2008; Soriano et al., 2008; Wahl et al., 2009; Xu et al., 2009; Hardingham and Bading, 2010).”
BackgroundNeurotransmitters and neuromodulators in the basal ganglia
Graybiel, A. M. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90104-i · Cited by 1,576
Regulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561 · cited 2×
“, 2006), the STriatal Enriched tyrosine Phosphatase (STEP) dephosphorylates the GluN2B tyrosine 1472 residue, leading to reduced synaptic NMDAR expression (Pelkey et al., 2002; Prybylowski et al., 2005; Snyder et al., 2005; Braithwaite et al., 2006).”
The neostriatal mosaic: multiple levels of compartmental organization
Gerfen, C. R. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90355-c · Cited by 1,467
Glutamate neurotoxicity in cortical cell culture
Choi, D., Maulucci-Gedde, M., & Kriegstein, A. (1987) · The Journal of Neuroscience · doi:10.1523/jneurosci.07-02-00357.1987 · Cited by 1,384
Functional Repression of cAMP Response Element in 6-Hydroxydopamine-treated Neuronal Cells
Chalovich, E. M., Zhu, J.-H., Caltagarone, J., Bowser, R., & Chu, C. T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602632200 · Cited by 1,371
G. Vonsattel, J. P., & DiFiglia, M. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199805000-00001 · Cited by 1,306
PSD-95 Involvement in Maturation of Excitatory Synapses
El-Husseini, A. E.-D., Schnell, E., Chetkovich, D. M., Nicoll, R. A., & Bredt, D. S. (2000) · Science · doi:10.1126/science.290.5495.1364 · Cited by 1,303
Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid
Beal, M. F., Kowall, N. W., Ellison, D. W., Mazurek, M. F., Swartz, K. J., & Martin, J. B. (1986) · Nature · doi:10.1038/321168a0 · Cited by 1,286
Quinolinic Acid: An Endogenous Metabolite That Produces Axon-Sparing Lesions in Rat Brain
Schwarcz, R., Whetsell, W. O., & Mangano, R. M. (1983) · Science · doi:10.1126/science.6849138 · Cited by 1,263
Lesion of striatal neurons with kainic acid provides a model for Huntington's chorea
COYLE, J. T., & SCHWARCZ, R. (1976) · Nature · doi:10.1038/263244a0 · Cited by 1,248
Reversal of Neuropathology and Motor Dysfunction in a Conditional Model of Huntington's Disease
Yamamoto, A., Lucas, J. J., & Hen, R. (2000) · Cell · doi:10.1016/s0092-8674(00)80623-6 · Cited by 1,067
The Toxic Effect of Sodium L-Glutamate on the Inner Layers of the Retina
LUCAS, D. R., & NEWHOUSE, J. P. (1957) · Archives of Ophthalmology · doi:10.1001/archopht.1957.00940010205006 · Cited by 1,063
Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines
Panov, A. V., Gutekunst, C.-A., Leavitt, B. R., Hayden, M. R., Burke, J. R., Strittmatter, W. J., & Greenamyre, J. T. (2002) · Nature Neuroscience · doi:10.1038/nn884 · Cited by 1,030
Beal, M., Brouillet, E., Jenkins, B., Ferrante, R., Kowall, N., Miller, J., Storey, E., Srivastava, R., Rosen, B., & Hyman, B. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-10-04181.1993 · Cited by 1,027
The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia
Gerfen, C. R. (1992) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.15.030192.001441 · Cited by 1,004
Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system
Ehlers, M. D. (2003) · Nature Neuroscience · doi:10.1038/nn1013 · Cited by 977
Synaptic organisation of the basal ganglia
BOLAM, J. P., HANLEY, J. J., BOOTH, P. A. C., & BEVAN, M. D. (2000) · Journal of Anatomy · doi:10.1046/j.1469-7580.2000.19640527.x · Cited by 948
Carter, R. J., Lione, L. A., Humby, T., Mangiarini, L., Mahal, A., Bates, G. P., Dunnett, S. B., & Morton, A. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-08-03248.1999 · Cited by 947
Mayer, M. L., & Westbrook, G. L. (1987) · The Journal of Physiology · doi:10.1113/jphysiol.1987.sp016883 · Cited by 931
Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond
Lipton, S. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1958 · Cited by 909
Disinhibition as a basic process in the expression of striatal functions
Chevalier, G., & Deniau, J. M. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90109-n · Cited by 865
Differential loss of striatal projection neurons in Huntington disease.
Reiner, A., Albin, R. L., Anderson, K. D., D'Amato, C. J., Penney, J. B., & Young, A. B. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.15.5733 · Cited by 839
MCGEER, E. G., & MCGEER, P. L. (1976) · Nature · doi:10.1038/263517a0 · Cited by 834
Hodgson, J. G., Agopyan, N., Gutekunst, C.-A., Leavitt, B. R., LePiane, F., Singaraja, R., Smith, D. J., Bissada, N., McCutcheon, K., Nasir, J., et al. (1999) · Neuron · doi:10.1016/s0896-6273(00)80764-3 · Cited by 830
Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity
Arundine, M., & Tymianski, M. (2003) · Cell Calcium · doi:10.1016/s0143-4160(03)00141-6 · Cited by 820
Role of Distinct NMDA Receptor Subtypes at Central Synapses
Cull-Candy, S. G., & Leszkiewicz, D. N. (2004) · Science's STKE · doi:10.1126/stke.2552004re16 · Cited by 804
Detection of Huntington's disease decades before diagnosis: the Predict-HD study
Paulsen, J. S., Langbehn, D. R., Stout, J. C., Aylward, E., Ross, C. A., Nance, M., Guttman, M., Johnson, S., MacDonald, M., Beglinger, L. J., et al. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.128728 · Cited by 804
Gerfen, C., Herkenham, M., & Thibault, J. (1987) · The Journal of Neuroscience · doi:10.1523/jneurosci.07-12-03915.1987 · Cited by 803
Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease
Slow, E. J. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg169 · Cited by 800
Tovar, K. R., & Westbrook, G. L. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-10-04180.1999 · Cited by 786
Liu, Y., Wong, T. P., Aarts, M., Rooyakkers, A., Liu, L., Lai, T. W., Wu, D. C., Lu, J., Tymianski, M., Craig, A. M., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0116-07.2007 · Cited by 773
Selective Sparing of a Class of Striatal Neurons in Huntington's Disease
Ferrante, R. J., Kowall, N. W., Beal, M. F., Richardson, E. P., Bird, E. D., & Martin, J. B. (1985) · Science · doi:10.1126/science.2931802 · Cited by 757
Coordinated Expression of Dopamine Receptors in Neostriatal Medium Spiny Neurons
Surmeier, D. J., Song, W.-J., & Yan, Z. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-20-06579.1996 · Cited by 747
Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models
Kreitzer, A. C., & Malenka, R. C. (2007) · Nature · doi:10.1038/nature05506 · Cited by 735
Decreased expression of striatal signaling genes in a mouse model of Huntington's disease
Luthi-Carter, R. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.9.1259 · Cited by 720
Gray, M., Shirasaki, D. I., Cepeda, C., Andre, V. M., Wilburn, B., Lu, X.-H., Tao, J., Yamazaki, I., Li, S.-H., Sun, Y. E., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0857-08.2008 · Cited by 613
Self-citationThe thalamostriatal system: a highly specific network of the basal ganglia circuitry
Smith, Y., Raju, D. V., Pare, J.-F., & Sidibe, M. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.07.004 · Cited by 602
Coyle, J. T., Molliver, M. E., & Kuhar, M. J. (1978) · Journal of Comparative Neurology · doi:10.1002/cne.901800208 · Cited by 596
Zeron, M. M., Hansson, O., Chen, N., Wellington, C. L., Leavitt, B. R., Brundin, P., Hayden, M. R., & Raymond, L. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00615-3 · Cited by 595
Self-citationNeurological abnormalities in a knock-in mouse model of Huntington's disease
Lin, C.-H. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.2.137 · Cited by 592
Synaptic Strength Regulated by Palmitate Cycling on PSD-95
El-Husseini, A. E.-D., Schnell, E., Dakoji, S., Sweeney, N., Zhou, Q., Prange, O., Gauthier-Campbell, C., Aguilera-Moreno, A., Nicoll, R. A., & Bredt, D. S. (2002) · Cell · doi:10.1016/s0092-8674(02)00683-9 · Cited by 568
Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin
Kawaguchi, Y., Wilson, C., & Emson, P. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-10-03421.1990 · Cited by 565
Role of brain-derived neurotrophic factor in Huntington's disease
ZUCCATO, C., & CATTANEO, E. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.01.003 · Cited by 552
Molecular determinants of NMDA receptor internalization
Roche, K. W., Standley, S., McCallum, J., Dune Ly, C., Ehlers, M. D., & Wenthold, R. J. (2001) · Nature Neuroscience · doi:10.1038/90498 · Cited by 550
Fonnum, F., Storm-Mathisen, J., & Divac, I. (1981) · Neuroscience · doi:10.1016/0306-4522(81)90168-8 · Cited by 542
Menalled, L. B., Sison, J. D., Dragatsis, I., Zeitlin, S., & Chesselet, M. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10776 · Cited by 536
White, J. K., Auerbach, W., Duyao, M. P., Vonsattel, J.-P., Gusella, J. F., Joyner, A. L., & MacDonald, M. E. (1997) · Nature Genetics · doi:10.1038/ng1297-404 · Cited by 534
Milnerwood, A. J., Gladding, C. M., Pouladi, M. A., Kaufman, A. M., Hines, R. M., Boyd, J. D., Ko, R. W. Y., Vasuta, O. C., Graham, R. K., Hayden, M. R., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.01.008 · Cited by 517
Self-citationSubunit-Specific NMDA Receptor Trafficking to Synapses
Barria, A., & Malinow, R. (2002) · Neuron · doi:10.1016/s0896-6273(02)00776-6 · Cited by 515 · cited 1×
“Notably, a variety of studies suggest that GluN2Bcontaining NMDARs predominate at extrasynaptic sites (Kew et al., 1998; Tovar and Westbrook, 1999; Barria and Malinow, 2002), although this point has been disputed (Groc et al., 2006; Thomas et al., 2006; Harris and Pettit, 2007; Petralia et al.,…”
BackgroundWilson, C., Chang, H., & Kitai, S. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-02-00508.1990 · Cited by 510
Evidence for more widespread cerebral pathology in early HD: An MRI-based morphometric analysis
Rosas, H. D., Koroshetz, W. J., Chen, Y. I., Skeuse, C., Vangel, M., Cudkowicz, M. E., Caplan, K., Marek, K., Seidman, L. J., Makris, N., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000065888.88988.6e · Cited by 505
Cha, J.-H. J., Kosinski, C. M., Kerner, J. A., Alsdorf, S. A., Mangiarini, L., Davies, S. W., Penney, J. B., Bates, G. P., & Young, A. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6480 · Cited by 504
Chronic quinolinic acid lesions in rats closely resemble Huntington's disease
Beal, M., Ferrante, R., Swartz, K., & Kowall, N. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-06-01649.1991 · Cited by 499
Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses
Papadia, S., Soriano, F. X., Léveillé, F., Martel, M.-A., Dakin, K. A., Hansen, H. H., Kaindl, A., Sifringer, M., Fowler, J., Stefovska, V., et al. (2008) · Nature Neuroscience · doi:10.1038/nn2071 · Cited by 498 · cited 5×
“Alterations in intracellular signaling systems differ for synaptic and extrasynaptic receptors in prodromal and early stages of Huntington’s disease Abbreviations AMPA α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate BAC Bacterial Artificial Chromosome BDNF Brain Derived Neurotrophic Factor Neuroscience.”
BackgroundInfluentialKim, M. J., Dunah, A. W., Wang, Y. T., & Sheng, M. (2005) · Neuron · doi:10.1016/j.neuron.2005.04.031 · Cited by 494
DAPK1 Interaction with NMDA Receptor NR2B Subunits Mediates Brain Damage in Stroke
Tu, W., Xu, X., Peng, L., Zhong, X., Zhang, W., Soundarapandian, M. M., Belal, C., Wang, M., Jia, N., Zhang, W., et al. (2010) · Cell · doi:10.1016/j.cell.2009.12.055 · Cited by 493 · cited 1×
“Recent studies suggest GluN2B-type NMDARs are preferentially linked to cell death signaling pathways compared to GluN2A-containing NMDARs (Kim et al., 2005; Liu et al., 2007; Tu et al., 2010).”
BackgroundA glutamatergic corticostriatal path?
McGeer, P. L., McGeer, E. G., Scherer, U., & Singh, K. (1977) · Brain Research · doi:10.1016/0006-8993(77)91003-4 · Cited by 486
Tang, T.-S., Tu, H., Chan, E. Y. W., Maximov, A., Wang, Z., Wellington, C. L., Hayden, M. R., & Bezprozvanny, I. (2003) · Neuron · doi:10.1016/s0896-6273(03)00366-0 · Cited by 481
Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity
Shin, J.-Y., Fang, Z.-H., Yu, Z.-X., Wang, C.-E., Li, S.-H., & Li, X.-J. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200508072 · Cited by 477
Dichotomous Anatomical Properties of Adult Striatal Medium Spiny Neurons
Gertler, T. S., Chan, C. S., & Surmeier, D. J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2660-08.2008 · Cited by 471
Excitotoxic injury of the neostriatum: a model for Huntington's disease
DiFiglia, M. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90111-m · Cited by 471
Wheeler, V. C. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.4.503 · Cited by 469
Re-emergence of striatal cholinergic interneurons in movement disorders
Pisani, A., Bernardi, G., Ding, J., & Surmeier, D. J. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.07.008 · Cited by 466
Striatal lesions with kainic acid: neurochemical characteristics
Schwarcz, R., & Coyle, J. T. (1977) · Brain Research · doi:10.1016/0006-8993(77)90538-8 · Cited by 466
II. Excitotoxic models for neurodegenerative disorders
Schwarcz, R., Foster, A. C., French, E. D., Whetsell, W. O., & Köhler, C. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90148-6 · Cited by 466
Microglial activation correlates with severity in Huntington disease: A clinical and PET study
Pavese, N., Gerhard, A., Tai, Y. F., Ho, A. K., Turkheimer, F., Barker, R. A., Brooks, D. J., & Piccini, P. (2006) · Neurology · doi:10.1212/01.wnl.0000222734.56412.17 · Cited by 462 · cited 1×
“Alterations in microglial activation, leading to enhanced release of the endogenous NMDAR agonist quinolinate (Guidetti et al., 2004; Pavese et al., 2006; Tai et al., 2007), could also contribute to stimulation of ExNMDARs.”
BackgroundCerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity
Rosas, H. D., Salat, D. H., Lee, S. Y., Zaleta, A. K., Pappu, V., Fischl, B., Greve, D., Hevelone, N., & Hersch, S. M. (2008) · Brain · doi:10.1093/brain/awn025 · Cited by 460
Okamoto, S.-I., Pouladi, M. A., Talantova, M., Yao, D., Xia, P., Ehrnhoefer, D. E., Zaidi, R., Clemente, A., Kaul, M., Graham, R. K., et al. (2009) · Nature Medicine · doi:10.1038/nm.2056 · Cited by 436
Huntingtin Interacting Proteins Are Genetic Modifiers of Neurodegeneration
Kaltenbach, L. S., Romero, E., Becklin, R. R., Chettier, R., Bell, R., Phansalkar, A., Strand, A., Torcassi, C., Savage, J., Hurlburt, A., et al. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030082 · Cited by 434
GABAergic microcircuits in the neostriatum
Tepper, J. M., Koós, T., & Wilson, C. J. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.08.007 · Cited by 434
Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease
Turmaine, M., Raza, A., Mahal, A., Mangiarini, L., Bates, G. P., & Davies, S. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.110078997 · Cited by 430
Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues
Strong, T. V., Tagle, D. A., Valdes, J. M., Elmer, L. W., Boehm, K., Swaroop, M., Kaatz, K. W., Collins, F. S., & Albin, R. L. (1993) · Nature Genetics · doi:10.1038/ng1193-259 · Cited by 416
N-Methyl-d-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease
FAN, M., & RAYMOND, L. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.11.003 · Cited by 413
Self-citationReplicating Huntington's disease phenotype in experimental animals
Brouillet, E. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00005-2 · Cited by 413
Huntington's disease: from pathology and genetics to potential therapies
Imarisio, S., Carmichael, J., Korolchuk, V., Chen, C.-W., Saiki, S., Rose, C., Krishna, G., Davies, J. E., Ttofi, E., Underwood, B. R., et al. (2008) · Biochemical Journal · doi:10.1042/bj20071619 · Cited by 409
Murphy, K. P. S. J., Carter, R. J., Lione, L. A., Mangiarini, L., Mahal, A., Bates, G. P., Dunnett, S. B., & Morton, A. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-13-05115.2000 · Cited by 398
NMDA Receptor Losses in Putamen from Patients with Huntington's Disease
Young, A. B., Greenamyre, J. T., Hollingsworth, Z., Albin, R., D'Amato, C., Shoulson, I., & Penney, J. B. (1988) · Science · doi:10.1126/science.2841762 · Cited by 395
Regulation of NMDA receptors by phosphorylation
Chen, B.-S., & Roche, K. W. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.05.018 · Cited by 389
Prybylowski, K., Chang, K., Sans, N., Kan, L., Vicini, S., & Wenthold, R. J. (2005) · Neuron · doi:10.1016/j.neuron.2005.08.016 · Cited by 385
Evidence for specific cognitive deficits in preclinical Huntington's disease
Lawrence, A. (1998) · Brain · doi:10.1093/brain/121.7.1329 · Cited by 384
Lione, L. A., Carter, R. J., Hunt, M. J., Bates, G. P., Morton, A. J., & Dunnett, S. B. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-23-10428.1999 · Cited by 384
Xia, P., Chen, H.-S. V., Zhang, D., & Lipton, S. A. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2488-10.2010 · Cited by 379
NMDA receptor surface mobility depends on NR2A-2B subunits
Groc, L., Heine, M., Cousins, S. L., Stephenson, F. A., Lounis, B., Cognet, L., & Choquet, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605238103 · Cited by 373
Distinct Roles of GABAergic Interneurons in the Regulation of Striatal Output Pathways
Gittis, A. H., Nelson, A. B., Thwin, M. T., Palop, J. J., & Kreitzer, A. C. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4870-09.2010 · Cited by 368
Albin, R. L., Reiner, A., Anderson, K. D., Dure, L. S., Handelin, B., Balfour, R., Whetsell, W. O., Penney, J. B., & Young, A. B. (1992) · Annals of Neurology · doi:10.1002/ana.410310412 · Cited by 368
Kita, H., & Kitai, S. T. (1988) · Brain Research · doi:10.1016/0006-8993(88)91138-9 · Cited by 364
Disturbed Ca2+signaling and apoptosis of medium spiny neurons in Huntington's disease
Tang, T.-S., Slow, E., Lupu, V., Stavrovskaya, I. G., Sugimori, M., Llinás, R., Kristal, B. S., Hayden, M. R., & Bezprozvanny, I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409402102 · Cited by 360
Transgenic rat model of Huntington's disease
von Horsten, S. (2003) · Human Molecular Genetics · doi:10.1093/hmg/12.6.617 · Cited by 359
Levine, M. S., Klapstein, G. J., Koppel, A., Gruen, E., Cepeda, C., Vargas, M. E., Jokel, E. S., Carpenter, E. M., Zanjani, H., Hurst, R. S., et al. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19991115)58:4<515::aid-jnr5>3.0.co;2-f · Cited by 352
Self-citationRosas, H. D., Tuch, D. S., Hevelone, N. D., Zaleta, A. K., Vangel, M., Hersch, S. M., & Salat, D. H. (2006) · Movement Disorders · doi:10.1002/mds.20979 · Cited by 346
Faideau, M., Kim, J., Cormier, K., Gilmore, R., Welch, M., Auregan, G., Dufour, N., Guillermier, M., Brouillet, E., Hantraye, P., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq212 · Cited by 341
Calpain Activation in Huntington's Disease
Gafni, J., & Ellerby, L. M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-12-04842.2002 · Cited by 331
Synaptic Targeting of the Postsynaptic Density Protein PSD-95 Mediated by Lipid and Protein Motifs
Craven, S. E., El-Husseini, A. E., & Bredt, D. S. (1999) · Neuron · doi:10.1016/s0896-6273(00)80705-9 · Cited by 326
Early Loss of Neostriatal Striosome Neurons in Huntingtonʼs Disease
HEDREEN, J. C., & FOLSTEIN, S. E. (1995) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199501000-00013 · Cited by 326
Ramifications of the globus pallidus in the rat as indicated by patterns of immunohistochemistry
Haber, S. N., & Nauta, W. J. H. (1983) · Neuroscience · doi:10.1016/0306-4522(83)90291-9 · Cited by 323
Cepeda, C., Hurst, R. S., Calvert, C. R., Hernández-Echeagaray, E., Nguyen, O. K., Jocoy, E., Christian, L. J., Ariano, M. A., & Levine, M. S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-03-00961.2003 · Cited by 321
Self-citationIvanov, A., Pellegrino, C., Rama, S., Dumalska, I., Salyha, Y., Ben‐Ari, Y., & Medina, I. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.105510 · Cited by 319
NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum
Landwehrmeyer, G., Standaert, D., Testa, C., Penney, J., & Young, A. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-07-05297.1995 · Cited by 317
Van Raamsdonk, J. M., Pearson, J., Slow, E. J., Hossain, S. M., Leavitt, B. R., & Hayden, M. R. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0590-05.2005 · Cited by 317
Klapstein, G. J., Fisher, R. S., Zanjani, H., Cepeda, C., Jokel, E. S., Chesselet, M.-F., & Levine, M. S. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.86.6.2667 · Cited by 314
Self-citationImpaired Glutamate Uptake in the R6 Huntington's Disease Transgenic Mice
Liévens, J.-C., Woodman, B., Mahal, A., Spasic-Boscovic, O., Samuel, D., Kerkerian-Le Goff, L., & Bates, G. P. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0430 · Cited by 313
Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease
Milnerwood, A. J., & Raymond, L. A. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.08.002 · Cited by 312
Self-citationThe corticostriatal pathway in Huntington's disease
CEPEDA, C., WU, N., ANDRE, V, CUMMINGS, D., & LEVINE, M. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.11.001 · Cited by 310
Self-citationHuang, K., Yanai, A., Kang, R., Arstikaitis, P., Singaraja, R. R., Metzler, M., Mullard, A., Haigh, B., Gauthier-Campbell, C., Gutekunst, C.-A., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.027 · Cited by 310
Zhang, S.-J., Zou, M., Lu, L., Lau, D., Ditzel, D. A. W., Delucinge-Vivier, C., Aso, Y., Descombes, P., & Bading, H. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000604 · Cited by 309
Regional cortical thinning in preclinical Huntington disease and its relationship to cognition
Rosas, H. D., Hevelone, N. D., Zaleta, A. K., Greve, D. N., Salat, D. H., & Fischl, B. (2005) · Neurology · doi:10.1212/01.wnl.0000174432.87383.87 · Cited by 309
Albin, R. L., Reiner, A., Anderson, K. D., Penney, J. B., & Young, A. B. (1990) · Annals of Neurology · doi:10.1002/ana.410270403 · Cited by 292
Hardingham, G. E., Arnold, F. J. L., & Bading, H. (2001) · Nature Neuroscience · doi:10.1038/88380 · Cited by 290
Laforet, G. A., Sapp, E., Chase, K., McIntyre, C., Boyce, F. M., Campbell, M., Cadigan, B. A., Warzecki, L., Tagle, D. A., Reddy, P. H., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09112.2001 · Cited by 290
Self-citationSevere deficiencies in dopamine signaling in presymptomatic Huntington's disease mice
Bibb, J. A., Yan, Z., Svenningsson, P., Snyder, G. L., Pieribone, V. A., Horiuchi, A., Nairn, A. C., Messer, A., & Greengard, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120166397 · Cited by 289
Synaptic and Extrasynaptic NMDA Receptor NR2 Subunits in Cultured Hippocampal Neurons
Thomas, C. G., Miller, A. J., & Westbrook, G. L. (2006) · Journal of Neurophysiology · doi:10.1152/jn.00771.2005 · Cited by 285
Mitochondria in Huntington's disease
Damiano, M., Galvan, L., Déglon, N., & Brouillet, E. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.07.012 · Cited by 284
Inhibition of Calpain Cleavage of Huntingtin Reduces Toxicity
Gafni, J., Hermel, E., Young, J. E., Wellington, C. L., Hayden, M. R., & Ellerby, L. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401267200 · Cited by 281
Miller, B. R., Dorner, J. L., Shou, M., Sari, Y., Barton, S. J., Sengelaub, D. R., Kennedy, R. T., & Rebec, G. V. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.02.004 · Cited by 280 · cited 6×
“…correlated firing and coincident bursts between pairs of MSNs were prominent in cells from WT animals, but reduced in R6/2 and knock-in models (Miller et al., 2008b) suggesting that information processing at both the single-neuron and population level is compromised in the striatum of…”
BackgroundResultInfluentialXu, J., Kurup, P., Zhang, Y., Goebel-Goody, S. M., Wu, P. H., Hawasli, A. H., Baum, M. L., Bibb, J. A., & Lombroso, P. J. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2212-09.2009 · Cited by 280
Lei, W., Jiao, Y., Del Mar, N., & Reiner, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1990-04.2004 · Cited by 277
Recurrent Connection Patterns of Corticostriatal Pyramidal Cells in Frontal Cortex
Morishima, M., & Kawaguchi, Y. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0252-06.2006 · Cited by 275
NMDA receptor function in mouse models of Huntington disease
Cepeda, C., Ariano, M. A., Calvert, C. R., Flores‐Hernández, J., Chandler, S. H., Leavitt, B. R., Hayden, M. R., & Levine, M. S. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1244 · Cited by 274
Self-citationOrexin loss in Huntington's disease
Petersén, Å., Gil, J., Maat-Schieman, M. L. C., Björkqvist, M., Tanila, H., Araújo, I. M., Smith, R., Popovic, N., Wierup, N., Norlén, P., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi004 · Cited by 271
Shelbourne, P. F., Killeen, N., Hevner, R. F., Johnston, H. M., Tecott, L., Lewandoski, M., Ennis, M., Ramirez, L., Li, Z., Iannicola, C., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.5.763 · Cited by 263
Bates, G. P., Murphy, K., Harper, P. S., & Jones, L. A. (2002) · Cited by 263
Papadia, S., Stevenson, P., Hardingham, N. R., Bading, H., & Hardingham, G. E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5019-04.2005 · Cited by 262
Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease
GUIDETTI, P., LUTHICARTER, R., AUGOOD, S., & SCHWARCZ, R. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.07.006 · Cited by 260
The GABA and substance P input to dopaminergic neurones in the substantia nigra of the rat
Bolam, J. P., & Smith, Y. (1990) · Brain Research · doi:10.1016/0006-8993(90)90811-o · Cited by 260
Léveillé, F., gaamouch, F. E., Gouix, E., Lecocq, M., Lobner, D., Nicole, O., & Buisson, A. (2008) · The FASEB Journal · doi:10.1096/fj.08-107268 · Cited by 257
Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease
Ferrante, R. J., Flint Beal, M., Kowall, N. W., Richardson, E. P., & Martin, J. B. (1987) · Brain Research · doi:10.1016/0006-8993(87)90694-9 · Cited by 257
Subunit-Specific Regulation of NMDA Receptor Endocytosis
Lavezzari, G., McCallum, J., Dewey, C. M., & Roche, K. W. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1890-04.2004 · Cited by 246
Ferrante, R. J., Kowall, N. W., Cipolloni, P. B., Storey, E., & Beal, M. F. (1993) · Experimental Neurology · doi:10.1006/exnr.1993.1006 · Cited by 244
Albin, R. L., Young, A. B., Penney, J. B., Handelin, B., Balfour, R., Anderson, K. D., Markel, D. S., Tourtellotte, W. W., & Reiner, A. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005033221807 · Cited by 243
Shuen, J. A., Chen, M., Gloss, B., & Calakos, N. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5492-07.2008 · Cited by 242
Ginovart, N. (1997) · Brain · doi:10.1093/brain/120.3.503 · Cited by 241
Reiner, A., Jiao, Y., Del Mar, N., Laverghetta, A. V., & Lei, W. L. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10541 · Cited by 241
Huntington's disease: the challenge for cell biologists
Tobin, A. J., & Signer, E. R. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01853-5 · Cited by 229
Organization of NMDA receptors at extrasynaptic locations
Petralia, R. S., Wang, Y. X., Hua, F., Yi, Z., Zhou, A., Ge, L., Stephenson, F. A., & Wenthold, R. J. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.01.022 · Cited by 227
Kew, J. N. C., Richards, J. G., Mutel, V., & Kemp, J. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-06-01935.1998 · Cited by 226
Hickey, M. A., Kosmalska, A., Enayati, J., Cohen, R., Zeitlin, S., Levine, M. S., & Chesselet, M.-F. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.08.041 · Cited by 226
Self-citationCasein Kinase 2 Regulates the NR2 Subunit Composition of Synaptic NMDA Receptors
Sanz-Clemente, A., Matta, J. A., Isaac, J. T. R., & Roche, K. W. (2010) · Neuron · doi:10.1016/j.neuron.2010.08.011 · Cited by 223
Immunohistochemical evidence for a dynorphin immunoreactive striato-nigral pathway
Vincent, S., Hökfelt, T., Christensson, I., & Terenius, L. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90477-0 · Cited by 223
Singaraja, R. R. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.23.2815 · Cited by 222
Gu, X., Li, C., Wei, W., Lo, V., Gong, S., Li, S.-H., Iwasato, T., Itohara, S., Li, X.-J., Mody, I., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.03.025 · Cited by 221
Menalled, L. B., Sison, J. D., Wu, Y., Olivieri, M., Li, X.-J., Li, H., Zeitlin, S., & Chesselet, M.-F. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-18-08266.2002 · Cited by 219
Dual Palmitoylation of NR2 Subunits Regulates NMDA Receptor Trafficking
Hayashi, T., Thomas, G. M., & Huganir, R. L. (2009) · Neuron · doi:10.1016/j.neuron.2009.08.017 · Cited by 219
Deng, Y. P., Albin, R. L., Penney, J. B., Young, A. B., Anderson, K. D., & Reiner, A. (2004) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2004.02.005 · Cited by 217
Parthasarathy, H. B., & Graybiel, A. M. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-07-02477.1997 · Cited by 214
Backman, L. (1997) · Brain · doi:10.1093/brain/120.12.2207 · Cited by 210
Greene, J. G., Porter, R. H. P., Eller, R. V., & Greenamyre, J. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03634.x · Cited by 208
Tyrosine phosphatase STEP is a tonic brake on induction of long-term potentiation
Pelkey, K. A., Askalan, R., Paul, S., Kalia, L. V., Nguyen, T.-H., Pitcher, G. M., Salter, M. W., & Lombroso, P. J. (2002) · Neuron · doi:10.1016/s0896-6273(02)00633-5 · Cited by 208
Huntington's disease: a synaptopathy?
Li, J.-Y., Plomann, M., & Brundin, P. (2003) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2003.08.006 · Cited by 208
Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington’s disease
Thu, D. C. V., Oorschot, D. E., Tippett, L. J., Nana, A. L., Hogg, V. M., Synek, B. J., Luthi-Carter, R., Waldvogel, H. J., & Faull, R. L. M. (2010) · Brain · doi:10.1093/brain/awq047 · Cited by 206
Sensory processing in Parkinson's and Huntington's disease
Boecker, H., Ceballos-Baumann, A., Bartenstein, P., Weindl, A., Siebner, H. R., Fassbender, T., Munz, F., Schwaiger, M., & Conrad, B. (1999) · Brain · doi:10.1093/brain/122.9.1651 · Cited by 205
Extrasynaptic and synaptic NMDA receptors form stable and uniform pools in rat hippocampal slices
Harris, A. Z., & Pettit, D. L. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.137679 · Cited by 202
Feedforward and feedback inhibition in neostriatal GABAergic spiny neurons
Tepper, J. M., Wilson, C. J., & Koós, T. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.10.008 · Cited by 202
Mechanisms underlying NMDA receptor synaptic/extrasynaptic distribution and function
Gladding, C. M., & Raymond, L. A. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2011.05.001 · Cited by 198
Self-citationCepeda, C., André, V. M., Yamazaki, I., Wu, N., Kleiman‐Weiner, M., & Levine, M. S. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06038.x · Cited by 198
Self-citationCicchetti, F., Prensa, L., Wu, Y., & Parent, A. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00039-4 · Cited by 193
Postsynaptic Density Protein-95 Regulates NMDA Channel Gating and Surface Expression
Lin, Y., Skeberdis, V. A., Francesconi, A., Bennett, M. V. L., & Zukin, R. S. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3159-04.2004 · Cited by 193
Bilateral globus pallidus stimulation for Huntington's disease
Moro, E., Lang, A. E., Strafella, A. P., Poon, Y. W., Arango, P. M., Dagher, A., Hutchison, W. D., & Lozano, A. M. (2004) · Annals of Neurology · doi:10.1002/ana.20183 · Cited by 191
Dopamine and Glutamate in Huntington's Disease: A Balancing Act
André, V. M., Cepeda, C., & Levine, M. S. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00134.x · Cited by 189
Self-citationGoebel-Goody, S. M., Davies, K. D., Alvestad Linger, R. M., Freund, R. K., & Browning, M. D. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.11.006 · Cited by 188
Longitudinal Evaluation of theHdh(CAG)150Knock-In Murine Model of Huntington's Disease
Heng, M. Y., Tallaksen‐Greene, S. J., Detloff, P. J., & Albin, R. L. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1830-07.2007 · Cited by 187
Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect
Levine, M. S., Cepeda, C., Hickey, M. A., Fleming, S. M., & Chesselet, M.-F. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.08.008 · Cited by 183
Self-citationSubtype‐Specific Enhancement of NMDA Receptor Currents by Mutant Huntingtin
Chen, N., Luo, T., Wellington, C., Metzler, M., McCutcheon, K., Hayden, M. R., & Raymond, L. A. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0721890.x · Cited by 180
Self-citationVan Raamsdonk, J. M., Murphy, Z., Slow, E. J., Leavitt, B. R., & Hayden, M. R. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi407 · Cited by 180
Hantraye, P., Riche, D., Maziere, M., & Isacson, O. (1990) · Experimental Neurology · doi:10.1016/0014-4886(90)90014-j · Cited by 175
Specific Targeting of Pro-Death NMDA Receptor Signals with Differing Reliance on the NR2B PDZ Ligand
Soriano, F. X., Martel, M., Papadia, S., Vaslin, A., Baxter, P. S., Rickman, C., Forder, J. P., Tymianski, M., Duncan, R. R., Aarts, M. M., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1207-08.2008 · Cited by 175
Atrophy of the Hypothalamic Lateral Tuberal Nucleus in Huntingtonʼs Disease
Kremer, H. P. H., Roos, R. A. C., Dingjan, G., Bots, G. T. A. M., & Maran, E. (1990) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199007000-00002 · Cited by 172
Hansen, H. H., Briem, T., Dzietko, M., Sifringer, M., Voss, A., Rzeski, W., Zdzisinska, B., Thor, F., Heumann, R., Stepulak, A., et al. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.03.013 · Cited by 171
Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease
Milnerwood, A. J., Cummings, D. M., Dallérac, G. M., Brown, J. Y., Vatsavayai, S. C., Hirst, M. C., Rezaie, P., & Murphy, K. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl092 · Cited by 171
Self-citationZeron, M. M., Fernandes, H. B., Krebs, C., Shehadeh, J., Wellington, C. L., Leavitt, B. R., Baimbridge, K. G., Hayden, M. R., & Raymond, L. A. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2003.11.014 · Cited by 170
Self-citationJoshi, P. R., Wu, N.-P., André, V. M., Cummings, D. M., Cepeda, C., Joyce, J. A., Carroll, J. B., Leavitt, B. R., Hayden, M. R., Levine, M. S., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5687-08.2009 · Cited by 169
Self-citationAlterations in Cortical Excitation and Inhibition in Genetic Mouse Models of Huntington's Disease
Cummings, D. M., André, V. M., Uzgil, B. O., Gee, S. M., Fisher, Y. E., Cepeda, C., & Levine, M. S. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.1592-09.2009 · Cited by 169
Self-citationHuntington's disease progression
Andrews, T. C., Weeks, R. A., Turjanski, N., Gunn, R. N., Watkins, L. H. A., Sahakian, B., Hodges, J. R., Rosser, A. E., Wood, N. W., & Brooks, D. J. (1999) · Brain · doi:10.1093/brain/122.12.2353 · Cited by 169
Bohanna, I., Georgiou-Karistianis, N., Hannan, A. J., & Egan, G. F. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.04.001 · Cited by 168
Pouladi, M. A., Graham, R. K., Karasinska, J. M., Xie, Y., Santos, R. D., Petersén, Å., & Hayden, M. R. (2008) · Brain · doi:10.1093/brain/awp006 · Cited by 166
Hansson, O., Guatteo, E., Mercuri, N. B., Bernardi, G., Li, X., Castilho, R. F., & Brundin, P. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01767.x · Cited by 165
Paladini, C. A., & Tepper, J. M. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19990601)32:3<165::aid-syn3>3.0.co;2-n · Cited by 164
Berretta, S., Parthasarathy, H. B., & Graybiel, A. M. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-12-04752.1997 · Cited by 164
Jiang, X., Tian, F., Mearow, K. M., Okagaki, P., Lipsky, R. H., & Marini, A. M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03200.x · Cited by 163
Selective Activation Induced Cleavage of the NR2B Subunit by Calpain
Simpkins, K. L., Guttmann, R. P., Dong, Y., Chen, Z., Sokol, S. A., Neumar, R. W., & Lynch, D. R. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-36-11322.2003 · Cited by 162
Sapp, E., Ge, P., Aizawa, H., Bird, E., Penney, J., Young, A. B., Vonsattel, J.-P., & Difiglia, M. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00427-7 · Cited by 161
The quinolinic acid model of Huntington's disease: Locomotor abnormalities
Sanberg, P. R., Calderon, S. F., Giordano, M., Tew, J. M., & Norman, A. B. (1989) · Experimental Neurology · doi:10.1016/0014-4886(89)90170-2 · Cited by 159
Abnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release
Li, H., Wyman, T., Yu, Z.-X., Li, S.-H., & Li, X.-J. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg218 · Cited by 157
Patel, S., Rademacher, D. J., & Hillard, C. J. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.054270 · Cited by 155
Mutant Huntingtin Expression Induces Mitochondrial Calcium Handling Defects in Clonal Striatal Cells
Milakovic, T., Quintanilla, R. A., & Johnson, G. V. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603845200 · Cited by 155
Imaging microglial activation in Huntington's disease
Tai, Y., Pavese, N., Gerhard, A., Tabrizi, S. J., Barker, R. A., Brooks, D. J., & Piccini, P. P. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.10.029 · Cited by 155
Mori, H., Manabe, T., Watanabe, M., Satoh, Y., Suzuki, N., Toki, S., Nakamura, K., Yagi, T., Kushiya, E., Takahashi, T., et al. (1998) · Neuron · doi:10.1016/s0896-6273(00)80567-x · Cited by 155
Cited by
Microglia-mediated neuroinflammation in neurodegenerative diseases
Subhramanyam, C. S., Wang, C., Hu, Q., & Dheen, S. T. (2019) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.05.004 · Cited by 870
Extrasynaptic NMDA Receptor Involvement in Central Nervous System Disorders
Parsons, M. P., & Raymond, L. A. (2014) · Neuron · doi:10.1016/j.neuron.2014.03.030 · Cited by 553
Self-citationGlutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration
Andersen, J. V., Markussen, K. H., Jakobsen, E., Schousboe, A., Waagepetersen, H. S., Rosenberg, P. A., & Aldana, B. I. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108719 · Cited by 371
Huntington's disease: underlying molecular mechanisms and emerging concepts
Labbadia, J., & Morimoto, R. I. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2013.05.003 · Cited by 369
A genetically encoded fluorescent sensor for in vivo imaging of GABA
Marvin, J. S., Shimoda, Y., Magloire, V., Leite, M., Kawashima, T., Jensen, T. P., Kolb, I., Knott, E. L., Novak, O., Podgorski, K., et al. (2019) · Nature Methods · doi:10.1038/s41592-019-0471-2 · Cited by 354
Metadata
- Authors
- Raymond, L. A., André, V. M., Cepeda, C., Gladding, C. M., Milnerwood, A. J., & Levine, M. S.
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 2011-12
- Volume
- 198
- Pages
- 252-273
- ISSN
- 0306-4522 (ISSN-L)
- OpenAlex
- W2017901987
- Cited by
- 325
- References
- 297
- FWCI
- 9.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.